Study Group: Psychiatrists who Treat Anxiety Disorders (US)(?)
Council Members in this Study Group: 92
Request a survey with this Study Group
Leading Experts in this Study Group
Amit Vijapura, MDOwner
Amit Vijapura, MD
Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...
Psychiatrist
North Scottsdale Psychiatric Specialists
Robert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's re-psychotherapy and psychopharmacology and the treatment...
President
Red Oak Psychiatry Associates, P. A.
Lawrence Ginsberg, MD, is President and CEO of Red Oak Psychiatry Associates, PA, a multidisciplinary mental health group in Houston, Texas. Dr. Ginsberg's research interests include psychopharmacology, addiction medicine, and forensic psychiatry. His areas of clinical expertise are attention deficit...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Psychiatrists (US) | 1116 |
| Psychiatrists | 1458 |
| Psychiatrists who Treat Mood Disorders (US) | 118 |
| Mood Disorder Psychiatrists | 157 |
| Physicians who Treat ADHD (US) | 434 |
| Physicians who Treat Schizophrenia (US) | 344 |
| Physicians who Treat Depression (US) | 381 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This article tells you only that the drugs are equally effective, but not what that really means in real life.
This "report" tells you nothing that you need to know in order to assess the validity of these studies. We have always known that St. John's Wort has some effectiveness---but it certainly does not come without side-effects. Where is the information about the length of the studies, the relative...
Gamma secretase inhibitors are one of several kinds of drugs being studied for the prevention/amelioration of Alzheimer's. In concept they make sense.
All is not as it seems when reported in the press, especially the non-scientific press.
-Pharmacogenetic tests have not made it into the treatment or assessment process for most physicians. -Until the cost for these tests become negligible -- or, included in the cost of a particular antidepressant -- psychopharmacogenetic testing will not make it into the mainstream.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Private/For-Profit Healthcare Research Entity
- Non-Academic Community Hospital or Clinic
- Other Freestanding Healthcare Facility
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- President
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

